The Association of Brachial-Ankle Pulse Wave Velocity with 30-Minute Post-Challenge Plasma Glucose Levels in Korean Adults with No History of Type 2 Diabetes by Choi, Eun-Suk et al.
This is an Open Access article distributed under the terms of the Creative Commons At-
tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) 
which permits unrestricted non-commercial use, distribution, and reproduction in any 
medium, provided the original work is properly cited.
www.e-kdj.org Copyright © 2010 Korean Diabetes Association
The Association of Brachial-Ankle Pulse Wave Velocity 
with 30-Minute Post-Challenge Plasma Glucose Levels 
in Korean Adults with No History of Type 2 Diabetes
Eun-Suk Choi
1, Eun-Jung Rhee
1, Ji-Hoon Choi
1, Ji-Cheol Bae
1, Seung-Hyun Yoo
1, Won-Jun Kim
1, Se-Eun Park
1, 
Cheol-Young Park
1, Won-Young Lee
1, Yong-Kyun Cho
2, Ki-Won Oh
1, Sung-Woo Park
1, Sun-Woo Kim
1
1Department of Endocrinology and Metabolism, 
2Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan 
University School of Medicine, Seoul, Korea
Background:  Acute postprandial hyperglycemia is an important affector for atherosclerosis in subjects with glucose intolerance. 
We analyzed the relationship of brachial-ankle pulse wave velocity (baPWV) with fasting and post-challenge plasma glucose lev-
els according to different time points during oral glucose tolerance test (OGTT). 
Methods:  In 663 subjects with fasting hyperglycemia, 75 g OGTT were performed to confirm the glucose tolerant status, and 
fasting, post-challenge 30-minute and 120-minute glucose levels were measured. Anthropometric measurements were done, and 
fasting lipid profiles were measured. baPWV were measured in all subjects and the relationship between fasting, 30- and 120-min-
ute post-challenge glucose levels and baPWV were analyzed. 
Results:  Among the participants, 62.9% were prediabetes and 31.7% were diabetes. Mean baPWV value was significantly higher 
in subjects with diabetes compared with prediabetes group. In bivariate correlation analyses, age, blood pressure, total cholester-
ol, low density lipoprotein cholesterol, 30-minute and 120-minute post-challenge glucose levels showed significant positive cor-
relation with baPWV value. In multiple regression analysis, 30-minute post-challenge glucose level was a weak but significant 
determinant for mean baPWV value even after adjustment for other confounding variables. 
Conclusions:  Postprandial hyperglycemia, especially 30-minute glucose levels showed significant correlation with baPWV in 
subjects with fasting hyperglycemia. These results can imply the deleterious effect of acute hyperglycemic excursion on arterial 
stiffness in subjects with glucose intolerance. 
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INTRODUCTION
Recent works suggest a certain cutoff of elevated 1-hour plasma 
glucose during oral glucose tolerance test (OGTT) is a strong 
predictor of future risk for type 2 diabetes, suggesting the role 
of 1-hour post-challenge glucose in the alteration of glucose 
metabolism status as well as 2-hour post-challenge glucose 
[1,2]. A very recent work reported that elevated 1-hour post-
load plasma glucose level identifies subjects with normal glu-
cose tolerance but subclinical atherosclerosis measured by ca-
rotid intima-media thickness [3]. These results imply the im-
portance of acute post-challenge glucose excursions in the de-
velopment of atherosclerosis. 
  Arterial stiffness is an independent predictor of cardiovas-
cular morbidity and mortality [4,5]. In general, stiffer arteries 
cause an early return of the pressure waves from reflectance 
sites and can be detected as an increase in the pulse wave veloc-
ity (PWV). Recently a simple device to measure brachial-ankle 
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PWV (baPWV) by recording the pulse volume at the upper 
arms and the ankles, has been developed [6]. baPWV corre-
lates well with carotid PWV (heart to carotid) and aortic PWV 
(carotid to femoral PWV) [7,8], and age, smoking, lipid pro-
files and hypertension are the known factors to affect arterial 
stiffness [9]. 
  A body of evidence suggests that atherosclerosis develops 
even from the prediabetic stage, implying the importance of 
early detection of subclinical atherosclerosis in much earlier 
period than the stage in which overt atherosclerosis develops 
in diabetic stage [10,11]. Furthermore, there is evidence that 
the metabolic alteration in type 2 diabetes and impaired glu-
cose metabolism are associated with increased arterial stiffness 
[11,12]. We analyzed the relationship of baPWV with fasting 
and post-challenge plasma glucose levels in different time points 
during OGTT in apparently healthy Korean subjects, and also 
compared these metabolic parameters in subjects with differ-
ent glucose tolerant status. 
 
METHODS
The study subjects
A total of 663 subjects (mean age, 47 years; ranged 30-78 years 
old) who performed 75 g OGTT in Department of Endocrinol-
ogy and Metabolism, Kangbuk Samsung Hospital, Seoul, Ko-
rea, between April to October 2003, were enrolled in the study. 
All of the participants were free of history for type 2 diabetes 
and were referred to the Endocrinology Department due to el-
evated fasting blood glucose (≥ 100 mg/dL) detected in Health 
Check-up Program in Health Promotion Center at Kangbuk 
Samsung Hospital. The glucose tolerance status of a subject was 
determined according to the criteria from American Diabetes 
Association [13]: normoglycemia (fasting glucose < 100 mg/
dL, post-challenge 2 hour-glucose < 140 mg/dL), prediabetes 
(impaired fasting glucose: 100 ≤ fasting glucose < 126 mg/dL, 
impaired glucose tolerance: 140 ≤ post-challenge 2-hour glu-
cose < 200 mg/dL) and diabetes (fasting glucose ≥ 126 mg/dL 
or post-challenge glucose ≥ 200 mg/dL).
  Subjects were excluded from the study if they had a history 
of cardiovascular disease including peripheral atherosclerosis, 
chronic gastrointestinal diseases associated with malabsorp-
tion, chronic pancreatitis, history of any malignant disease, 
history of alcohol or drug abuse, liver or kidney failure, and 
treatments able to modify glucose metabolism, such as steroid. 
The subjects with history of hypertension were included in the 
analyses and the presence of hypertension was defined when 
the subject was taking anti-hypertensive medication or mea-
sured systolic or diastolic blood pressures were same or above 
140/90 mm Hg [14]. Written informed consent was obtained 
from each participant and the study protocol conforms to the 
ethical guidelines of the 1975 Declaration of Helsinki as reflect-
ed in a priori approval by the institution’s Human Research 
Committee.
Laboratory assessment
Blood pressures (BP) were taken with a standardized sphyg-
momanometer after at least 5 minutes of rest. The heights and 
weights of the subjects were measured with individuals dressed 
in an examination gown wearing no shoes. The body mass in-
dex (BMI) was expressed as the weight in kilograms divided 
by the height in meters (kg/m
2). The waist circumference was 
measured in the standing position, at the level of umbilicus by 
a single examiner. 
  Blood samples were collected after at least 12 hours of fast-
ing. An enzymatic colorimetric test was used to measure total 
cholesterol (TC) and triglyceride concentrations. The selective 
inhibition method was used to measure the level of high den-
sity lipoprotein cholesterol (HDL-C), and a homogeneous en-
zymatic calorimetric test was used to measure the level of low 
density lipoprotein cholesterol (LDL-C) (Advia 1650 Autoan-
alyzer; Byer Diagnostics, Leverkusen, Germany). 
  After 8 hours of overnight fasting, a 75 g OGTT was per-
formed with 0, 30, and 120 minutes sampling for plasma glu-
cose and fasting insulin. Blood glucose levels were determined 
using the hexokinase method (Advia 1650 Autoanalyzer) and 
serum insulin concentration was determined with an immu-
noradiometric assay (Biosource, Fleurus, Belgium); this assay 
had intra- and inter-assay coefficients with a variation of 2.1–
4.5% and 4.7–12.2%, respectively. 
  The subjects’ insulin resistance status was calculated by   
using the homeostatic model assessment–insulin resistance 
(HOMA-IR) [15]. HbA1c was measured by high performance 
liquid chromatography using the Variant
TM II Turbo (Bio-Rad 
Laboratories, Hercules, CA, USA). The methodology was aligned 
with the Diabetes Control and Complications Trial (DCCT) 
and National Glycohemoglobin Standardization Program 
(NGSP) standards [16].
Assessment of arterial stiffness
Pulse-wave velocity were measured using a Waveform analyz-289
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er (VP-1000; Colin Co., Komaki, Japan), after at least 5 min-
utes rest. Two indices such as baPWV were obtained using a 
volume-plethysmographic apparatus by simultaneous BP and 
waveform measurements on all four limbs along with ECG 
and phonogram tracings. PWV was automatically calculated 
by time-phasic analysis using the following formula: distance 
between two sites divided by pulse wave transit time. baPWV 
was measured from the ascending point of right brachial pulse 
volume recorder to the ascending point of each ankle pulse vol-
ume recorder. The distance between the right brachium and 
ankle was estimated based on body height and derived from 
statistical studies [17]. All procedures took about 5 minutes. 
Mean baPWV value was calculated with (rt baPWV + lt baP-
WV)/2.
Statistical analysis 
All analyses were carried out with SPSS version 13.0 (SPSS Inc., 
Chicago, IL, USA). Bivariate correlation analyses were per-
formed to analyze the relationships between mean baPWV and 
the parameters and one-way ANOVA test was used to compare 
the mean values of the parameters between different glucose 
tolerance groups. Multiple regression analysis with backward 
method was performed to investigate the determinants for 
baPWV among the post-challenge glucose levels during 75 g 
OGTT after adjustment for the confounding variables. P value 
less than 0.05 was considered statistically significant. 
 
RESULTS
Clinical characteristics of the participants
Table 1 shows the general characteristics of the study popula-
tion. Mean age was 47.4 years and in 75 g OGTT test, 36 sub-
jects (5.4%) showed normoglycemia, 417 subjects (62.9%), 
prediabetes and 210 (31.7%) subjects were diabetic. The pro-
portion of subjects with hypertension was 27.6% (Table 1).
Comparisons of the metabolic parameters according to 
glucose tolerant status 
When the mean values of parameters are compared between 
the different glucose tolerance groups, waist circumference and 
BMI showed significantly higher mean values and HDL-C 
showed significantly lower mean value in diabetes subjects 
compared with non-diabetic groups (Table 2). 
  For HOMA-IR, diabetes subjects showed significantly 
higher value compared with prediabetes subjects (3.5 ± 1.4 vs. 
2.8 ± 1.0, P < 0.01) (Table 2). For baPWV values, mean values 
showed significantly higher values in diabetic subjects com-
pared with prediabetes group.
  There was no difference in the proportion of subjects with 
hypertension among the different glucose tolerance groups 
(Table 2).
Relationship between baPWV and metabolic parameters
In bivariate correlation analyses between baPWV and other 
parameters, mean baPWV showed significant positive correla-
Table 1.  The general characteristics of the subjects (n = 663)
Characteristics  
Age, yr 47.4 ± 9.1
Sex, M/F 484/179 (73/27)
Height, cm 167.1 ± 8.3
Body weight, kg 70.8 ± 10.6
Waist circumference, cm 84.6 ± 7.5
Body mass index, kg/m
2 25.3 ± 2.7
SBP, mm Hg 122.0 ± 15.5
DBP, mm Hg 78.8 ± 9.3
HbA1c, % 5.85 ± 0.68
75 g OGTT 0-min glucose, mg/dL 119.0 ± 18.6
75 g OGTT 30-min glucose, mg/dL 186.1 ± 34.1
75 g OGTT 120-min glucose, mg/dL 162.8 ± 56.7
HOMA-IR 3.03 ± 1.19
baPWV Rt, cm/sec 1,388.2 ± 203.1
baPWV Lt, cm/sec 1,388.6 ± 204.3
Mean baPWV, cm/sec 1,388.5 ± 201.5
Total cholesterol, mg/dL 206.4 ± 38.3
Triglyceride, mg/dL 176.5 ± 128.3
HDL-C, mg/dL 47.0 ± 10.2
LDL-C, mg/dL 124.1 ± 34.0
Hypertension 183 (27.6)
Glucose tolerance status in 75 g OGTT
Normal 36 (5.4)
Prediabetes 417 (62.9)
Diabetes mellitus 210 (31.7)
Data are presented as mean ± standard deviation or number (%) un-
less otherwise noted.
SBP, systolic blood pressure; DBP, diastolic blood pressure; OGTT, 
oral glucose tolerance test; HOMA-IR, homeostasis model assess-
ment-insulin resistance; baPWV, brachial-ankle pulse wave velocity; 
HDL-C, high density lipoprotein cholesterol; LDL-C, low density li-
poprotein cholesterol.290
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tions with age, blood pressure, TC, LDL-C, 30-minute and 
120-minute post-challenge glucose levels and mean HbA1c lev-
els, and negative correlations with weight and height (Table 3). 
In multiple regression analyses with backward method, age, 
30-minute post-challenge glucose, triglyceride and systolic 
blood pressure were the significant determinants for baPWV 
values after adjustment for confounding variables (Table 4).
 
DISCUSSION
In this study performed in subjects without a history of type 2 
diabetes, who were referred due to elevated fasting blood glu-
cose in a health check-up program, 30-minute post-challenge 
glucose levels in 75 g OGTT showed the most significant asso-
ciation with baPWV values, reflecting acute glucose excursion 
after glucose challenge affected arterial stiffness mostly other 
than 120-minute glucose. These significances were consistent 
even after adjustment for confounding factors, such as age, 
blood pressure and lipid profile, suggesting the association of 
30-minute glucose could be important effector for arterial 
stiffness. 
  Cardiovascular disease is one of the important causes for 
mortality in patients with diabetes mellitus, and the measure-
ment method for the vascular complication is very important. 
The importance for the assessment of arterial stiffness lies in 
its predictability for subclinical atherosclerosis and the preven-
tion of future cardiovascular events [18]. Arterial stiffness could 
be measured in many ways, including distensibility, pulse wave 
velocity and augmentation index. The arterial PWV, especially 
of the aorta, has emerged as an important independent predic-
tor of cardiovascular events, and it is reflected with the speed 
with which the arterial pressure wave progresses through the 
arterial tree, and this increases with increasing vascular stiff-
ness [9]. Increased PWV occurs with a range of estabilished 
Table 2.  Comparisons of the mean values of parameters between the subjects with different glucose tolerance status
Normal (n = 36) Prediabetes  (n = 417) Diabetes mellitus (n = 210) P value
Age, yr 49.2 ± 6.7 46.7 ± 9.2 48.3 ± 9.2 0.055
Height, cm 164.6 ± 7.8 167.4 ± 8.2 167.1 ± 8.5 0.157
Weight, kg 68.5 ± 12.6 70.5 ± 10.7 71.9 ± 10.1 0.111
Waist circumference, cm 84.7 ± 9.5 83.9 ± 7.4
a 86.0 ± 7.3
a 0.005
Body mass index, kg/m
2 25.1 ± 3.5 25.1 ± 2.7
a 25.7 ± 2.7
a 0.025
SBP, mm Hg 122. 6 ± 13.0 121.4 ± 16.0 123.1 ± 14.9 0.413
DBP, mm Hg 79.1 ± 8.5 78.4 ± 9.6 79.6 ± 8.9 0.293
Total cholesterol, mg/dL 210.0 ± 38.0 205.1 ± 37.7 208.6 ± 39.6 0.469
Triglyceride, mg/dL 139.4 ± 82.9 175.8 ± 133.5 184.9 ± 123.3 0.142
HDL-C, mg/dL 51.4 ± 10.9
a 47.5 ± 10.4 45.5 ± 9.4
a 0.002
LDL-C, mg/dL 127.3 ± 30.1 122.0 ± 32.3 128.1 ± 37.4 0.090
75 g OGTT 0-min glucose, mg/dL 92.79 ± 4.7
a 113.0 ± 8.1
a 134.6 ± 23.4
a < 0.01
75 g OGTT 30-min glucose, mg/dL 151.3 ± 28.5
a 175.6 ± 23.8
a 212.1 ± 36.6
a < 0.01
75 g OGTT 120-min glucose, mg/dL 109.5 ± 18.3
a 139.9 ± 26.8
a 215.6 ± 66.1
a < 0.01
HbA1c, % 5.60 ± 0.3
a 5.64 ± 0.3
b 6.33 ± 1.0
a,b < 0.01
HOMR-IR 3.1 ± 1.3 2.8 ± 1.0
a 3.5 ± 1.4
a < 0.01
baPWA Rt, cm/sec 1,377.0 ± 174.5 1,374.6 ± 199.6
a 1,417.7 ± 212.3
a 0.040
baPWA Lt, cm/sec 1,379.0 ± 204.2 1,373.6 ± 196.2
a 1,420.2 ± 217.3
a 0.025
Mean baPWV, cm/sec 1,379.0 ± 188.4 1,374.1 ± 195.7
a 1,419.0 ± 212.1
a 0.029
Hypertension 9 (25) 105 (25.2) 69 (49.8) 0.120
Data are presented as mean ± standard deviation or number (%) unless otherwise noted.
SBP, systolic blood pressure; DBP, diastolic blood pressure; OGTT, oral glucose tolerance test; HOMA-IR, homeostasis model assessment-insu-
lin resistance; baPWV, brachial-ankle pulse wave velocity; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein choles-
terol.
a,bSame footnotes denote significant differences of the mean values between the groups in post-hoc analyses.291
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cardiovascular risk factors, including age, hypercholesterol-
emia, smoking, and sedentary life style [18,19]. Diabetic pa-
tients have increased arterial stiffness, and compromised PWV 
have been demonstrated even before the onset of diabetes, in 
patients with impaired glucose tolerance [20]. Healthy offspring 
of type 2 diabetes patients have a higher PWV than matched 
controls [12,20]. Arterial stiffness in diabetes is related to prev-
alent CVA, and has shown to be an independent predictor of 
coronary heart disease [21]. In the Hoorn study, baseline dis-
tensibility did not predict mortality in subjects with impaired 
glucose tolerance during a follow-up period of 6.6 years [11]. 
In contrast, PWV seemed to have reasonable predictable value 
for mortality in patients with impaired glucose tolerance and 
type 2 diabetes mellitus [12].
  The importance of post-challenge glucose levels during 
OGTT other than 2-hour glucose levels, such as 30-minute or 
1-hour glucose level, in glucose metabolism has not been clear-
ly defined. Although glucose tolerance status is defined mainly 
by fasting and post-challenge 2-hour glucose levels, a few stud-
ies have suggested that a certain cutoff value of 1-hour glucose 
during OGTT can stratify subjects with normal glucose toler-
ance (NGT) into categories of low or high risk for development 
of type 2 diabetes [1,2]. In a recent study by Succurro et al. [3], 
NGT subjects with a 1-hour post-load glucose ≥ 155 mg/dL 
have an atherogenic profile including intima-media thickness 
similar to IGT subjects, suggesting the association of post-chal-
lenge glucose levels other than 2-hour glucose level with de-
velopment of atherosclerosis and diabetes mellitus. Although 
the role of other post-challenge glucose levels other than 2-hour 
glucose levels during OGTT in the relationship with develop-
ment of diabetes or atherosclerosis is not clearly defined, it is 
evident that acute hyperglycemia in response to oral glucose 
load suppresses endothelium-dependent vasodilation, increases 
oxidative stress, increases inflammatory response in vascula-
ture, all of which are processes involved in atherogenesis [22]. 
  In our study, post-challenge 30-minute glucose level showed 
significant correlation with baPWV values and this significance 
was significant even after adjustment for cardiovascular risk 
factors. This significance was stronger than those with fasting 
or 2-hour post-load glucose levels, implying the association of 
acute hyperglycemia after oral glucose loading with arterial 
stiffness. Large epidemiological studies, such as the Diabetes 
Epidemiology: Collaborative analysis Of Diagnostic criteria in 
Europe (DECODE) Study, have shown a stronger association 
of post-challenge glycemia with cardiovascular outcomes 
compared with fasting glucose level and higher glucose levels 
Table 3.  Bivariate correlations analyses between the parame-
ters with mean baPWV 
Correlation 
coefficient
P value
Age, yr 0.465 < 0.01
Height, cm -0.150 < 0.01
Weight, kg -0.102 < 0.01
Waist circumference, cm 0.041 0.294
Body mass index, kg/m
2 0.004 0.918
SBP, mm Hg 0.381 < 0.01
DBP, mm Hg 0.268 < 0.01
Total cholesterol, mg/dL 0.145 < 0.01
Triglyceride, mg/dL 0.027 0.484
HDL-C, mg/dL 0.054 0.162
LDL-C, mg/dL 0.126 < 0.01
75 g OGTT 0-min glucose, mg/dL 0.073 0.063
75 g OGTT 30-min glucose, mg/dL 0.174 < 0.01
75 g OGTT 120-min glucose, mg/dL 0.164 < 0.01
HbA1c, % 0.141 < 0.01
HOMR-IR 0.039 0.318
SBP, systolic blood pressure; DBP, diastolic blood pressure; OGTT, 
oral glucose tolerance test; HOMA-IR, homeostasis model assess-
ment-insulin resistance; baPWV, brachial-ankle pulse wave velocity; 
HDL-C, high density lipoprotein cholesterol; LDL-C, low density li-
poprotein cholesterol.
Table 4.  Backward multiple regression analysis with mean 
baPWV as the dependent variables 
beta P value
Age 0.438 < 0.01
Male gender -0.054 0.118
Body mass index -0.047 0.164
75 g OGTT 0-min glucose  0.011 0.796
75 g OGTT 30-min glucose  0.099 0.002
75 g OGTT 120-min glucose  0.060 0.138
Total cholesterol  0.038 0.262
Triglyceride  0.084 0.010
SBP 0.337 < 0.01
HOMA-IR 0.032 0.347
R
2 0.346
BaPWV, brachial-ankle pulse wave velocity; OGTT, oral glucose tol-
erance test; SBP, systolic blood pressure; HOMA-IR, homeostasis 
model assessment-insulin resistance.292
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after glucose challenge [23,24]. In the study by Kasayama et al. 
[7], 2-hour post-load glucose level in OGTT showed weak but 
significant correlation with PWV levels in male subjects. In 
another study performed in type 1 diabetes patients, acute hy-
perglycemia during hyperglycemic clamp test showed signifi-
cant correlation with increased baPWV, emphasizing the im-
portance of post-load glucose control in the development of 
atherosclerosis [5]. These results from the previous studies are 
similar with our study result in that post-load hyperglycemia 
is deleterious for the vessel, but differ from our study in that 
our study showed the association of rapidly increased post-
load glucose earlier than 2 hours with arterial stiffness. Fur-
ther well-designed studies are warranted to define the signifi-
cant role of 30-minute or 1-hour post-load glucose levels in 
the prediction of type 2 diabetes in NGT subjects and in the 
development of atherosclerosis.  
  Our study has limitations. As these study subjects were re-
ferred to Endocrinology Department due to the detection of at 
least one time of high fasting glucose level, all of the study sub-
jects could be categorized as having impaired fasting glucose. 
This could be the reason for the absence of difference in mean 
baPWV between subjects with normoglycemia and prediabe-
tes. However, significantly increased baPWV in diabetes sub-
jects compared with prediabetes subjects show the significant-
ly affected arterial stiffness according to glucose tolerant status. 
  In conclusion, our data suggests the association of post-chal-
lenge 30-minute glucose level during OGTT other than 120- 
minute or fasting glucose levels with arterial stiffness in Kore-
an subjects in whom 75 g OGTT was performed due to fasting 
hyperglycemia. This result warrants the further researches to 
clarify the significance of acute glucose excursions in the de-
velopment of atherosclerosis. 
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